Birgit C. Schultes, EVP, Chief Scientific Officer: Intellia Therapeutics NTLA Sell · Filed 01/07

Trade details

Type: Insider sale
Amount: $78,358.68
Shares · price: 8,508 sh · $9.21 a share
Held after: 98,533 sh
Stock: Intellia Therapeutics NTLA
Person: Birgit C. SchultesEVP, Chief Scientific Officer
Trade date: 26/01/05
Filed: 26/01/07
Days to filing: 2 days

Sold 7.9% of holdings

Share of holding sold: 7.9%

Intellia Therapeutics trades, last 26 weeks

What else happened in Intellia Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

Birgit C. Schultes's recent trades

Birgit C. SchultesEVP, Chief Scientific Officer
SellIntellia Therapeutics
Sell
Intellia Therapeutics
NTLA
$539
31 sh
$539
Filed 25/10/03
Traded 25/10/01